BUFFALO GROVE, Ill., Feb. 15, 2018 /PRNewswire-iReach/ -- Soprano ICE Platinum and TRIO Clustered Technology -
"The Soprano brand is supported by many years of clinical research and white papers," says Avi Farbstein, CEO of Alma Lasers North America. "The recent FDA clearance of our innovative TRIO applicator once again positions Alma Lasers as the leading technology provider in medical aesthetics. Soprano is the most recognized aesthetic brand in North America and we once again have changed the landscape in aesthetic medicine by introducing TRIO clustered diode technology."
Accent Prime, Next Generation Ultrasound and Radiofrequency Technology – Alma Lasers also showcases its new Accent Prime, the most advanced platform of its kind for aesthetic enhancement.
The Accent Prime gives providers the ability to offer the most in-demand treatments for face and body from one comprehensive, cost-efficient platform. The device boasts innovations such as Focused RF, Ultrasound and Micro Plasma Pixel (MPP) Technology with deep and superficial heating capabilities, allowing providers to increase efficiency and treatment precision.
With radiofrequency as the core technology, providers can offer treatments such as skin resurfacing to patients who previously did not qualify for such procedures. The ultrasound capabilities can also enhance treatments and raise patient satisfaction.
"In the past, radiofrequency has shown great promise," says Avi Farbstein. "But it's time for the promise stage to end and for the technology to deliver. The Accent Prime signals the beginning of a new era in treatments for the face and body."
AAD attendees can visit Alma Lasers in Booth #2656 to learn more about Soprano ICE Platinum and Accent Prime. Professionals not attending can visit the company's website or contact Kevin Mendell, Alma's Strategic Marketing Director, by email at firstname.lastname@example.org.
About Alma Lasers
Alma Lasers is a global innovator of laser, light-based, radiofrequency and ultrasound solutions for the aesthetic and surgical markets. We enable practitioners to offer safe and effective procedures while allowing patients to benefit from state-of-the-art, clinically proven technologies and treatments. For more information visit the company's website: http://www.almalasers.com/us/ or contact Kevin Mendell, Strategic Marketing Director, by email at email@example.com.
Media Contact: Kevin Mendell, Alma Lasers, 224-377-2000, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Alma Lasers, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All